Mayo Clinic News Network

News Resources

Items tagged as "Sean Dowdy"

Dowdy how bevacizumab is used (:31)

Sean Dowdy, M.D., a Mayo Clinic gynecologic oncologist describes a study showing molecular sequencing could identify ovarian cancer patients who are most likely to benefit from treatment with bevacizumab (Avastin), a Mayo Clinic-led study has found.

Created by Brian Kilen

Dowdy importance of collobaration in research (:21)a

Sean Dowdy, M.D., a Mayo Clinic gynecologic oncologist describes a study showing molecular sequencing could identify ovarian cancer patients who are most likely to benefit from treatment with bevacizumab (Avastin), a Mayo Clinic-led study has found.

Created by Brian Kilen

Dowdy individualized approach to treatment (:20)

Sean Dowdy, M.D., a Mayo Clinic gynecologic oncologist describes a study showing molecular sequencing could identify ovarian cancer patients who are most likely to benefit from treatment with bevacizumab (Avastin), a Mayo Clinic-led study has found.

Created by Brian Kilen

Dowdy need corroboration of data in other patients (:14)

Sean Dowdy, M.D., a Mayo Clinic gynecologic oncologist describes a study showing molecular sequencing could identify ovarian cancer patients who are most likely to benefit from treatment with bevacizumab (Avastin), a Mayo Clinic-led study has found.

Created by Brian Kilen

Mayo Clinic: Ovarian Cancer Subtypes May Predict Response to Bevacizumab

Mayo Clinic: Ovarian Cancer Subtypes May Predict Response to Bevacizumab

CHICAGO — Molecular sequencing could identify ovarian cancer patients who are most likely to benefit from treatment with bevacizumab (Avastin), a Mayo Clinic-led study has found. Results of the research were presented today at the 2014 American Society of Clinical Oncology Annual Meeting. The addition of bevacizumab to standard therapy [...]

Created by Joe Dangor

Ovarian Cancer Awareness: Mayo Clinic Experts Discuss Research, Treatment and Survivorship

Ovarian Cancer Awareness: Mayo Clinic Experts Discuss Research, Treatment and Survivorship

ROCHESTER, Minn. — September 5, 2012.  September is Ovarian Cancer Awareness Month. Ovarian cancer is the leading cause of death from gynecologic cancers in the nation and the fifth leading cause of cancer death among U.S. women. Although treatment advances have improved the average length of survival after diagnosis, the [...]

Created by Joe Dangor